Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 14 results found. Search for [ GVK BIO ]

Results 1 to 14 of 14
E Kumar Sharma
August 6, 2015
It is still not clear who is severely impacted by the ban. Because if the impact was huge on any company, it would have by now informed the stock exchanges.

E Kumar Sharma
July 28, 2015
European Union banned marketing of 700 generic drugs due to alleged manipulation of clinical trials conducted at GVK Biosciences.

E Kumar Sharma
July 26, 2015
\"GVK BIO is disappointed with the fact that even after multiple appeals, a deeper scientific dialogue was not undertaken\", the company said in a statement mailed to Business Today.

Zeba Siddiqui
Mumbai, April 15, 2015
India may go to WTO if the European Union does not reconsider its decision to suspend the sale of about 700 generic drugs that were approved based on clinical trials by GVK Biosciences, the firm said.

K Mammen Mathew
Berlin, January 24, 2015
The move is being seen as the EU's determination to maintain high ethical and medical standards for approval of medicines.

K Mammen Mathew
Berlin, December 10, 2014
The German drug regulator also suspended the marketing authorisation given to the drugs concerned based on the data of clinical trials supplied by GVK Biosciences.

Hyderabad, December 8, 2014
Replying to a query, company's CEO said it would cost about Rs 30 lakh to redo the studies, which the company is willing to bear on behalf of the clients.

E Kumar Sharma
December 6, 2014
\"We are clearly disappointed by the outcome and do feel it raises questions on the future viability of this business,\" Manni Kantipudi, CEO of GVK Biosciences told.

Hyderabad , November 6, 2014
The US-headquartered Vanta Bioscience offers toxicology evaluation services for pharmaceutical, biotech, food supplements and feed additives industries.

E. Kumar Sharma
January 29, 2014
Aragen is a privately held US-based, pre-clinical CRO specializing in high-value biologics services. As per the deal, GVK Bio will acquire the capital stock of Aragen Bioscience.

E. Kumar Sharma
January 29, 2013
Millions of Indians are grappling with the costs of cancer treatment, sometimes spending their life's savings on it.

E. Kumar Sharma
Hyderabad, January 9, 2013
The Hyderabad-based contract research organisation has inked an agreement with US-based Onconova Therapeutics to develop new cancer drugs.
August 20, 2008
Call it the six-year-itch. Set up in 2002 by GVK scion G.V. Sanjay Reddy, GVK Biosciences is now talking leadership and on ways to get there quickly.

By E. Kumar Sharma
October 17, 2007
India is critical to our future, says Robert R Ruffolo, 57, President, Wyeth Research & Development. That may sound like just another feel-good sound byte from a visiting foreign honcho, but Ruffolo and Wyeth have good reasons for banking on India.